Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONC | BEONE MEDICINES LTD | $310.30 | $7.17 | 4,225.64% | 6,206.00x | 218.35x | 6.88x | 8.32x | 16.72x | $529.27M | 1.55% | $4.13B | 37.48 | $32.24B | 101.37 | ||
| CORT | CORCEPT THERAPEUTICS INC | $79.82 | $27.15 | 193.94% | 79.82x | 80.68x | 11.15x | 13.29x | 1.39x | $162.57M | 1.97% | $631.90M | 6.10 | $8.28B | 125.46 | ||
| NVO | NOVO NORDISK A S | $51.47 | $139.24 | -63.04% | 14.31x | 2.17x | 4.70x | 8.74x | 0.16x | $9.34B | 4.08% | $26.18B | 5.89 | $239.36B | 9.65 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $398.82 | $30.22 | 1,219.56% | 1,286.52x | 213.02x | 16.33x | 225.27x | 5.20x | $221.36M | 0.42% | $233.89M | 1.78 | $54.41B | 358.16 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $8.82 | $11.79 | -25.18% | 18.38x | 6.76x | 5.85x | 3.73x | 0.36x | -$23.64M | -4.80% | $133.17M | 2.38 | $504.82M | 7.51 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $41.00 | $15.00 | 173.32% | 83.66x | 41.08x | 5.12x | 5.80x | 1.25x | $101.73M | 3.32% | $535.38M | 7.17 | $2.94B | 54.91 | ||
| GMAB | GENMAB A | $32.52 | $106.43 | -69.45% | 13.88x | 1.81x | 5.86x | 3.63x | 0.13x | $1.19B | 5.72% | $5.75B | 8.96 | $19.26B | 9.63 | ||
| ARGX | ARGENX SE | $837.45 | $283.62 | 195.28% | 33.47x | 46.75x | 27,014.52x | 7.13x | 2.25x | $467.72M | 0.92% | $7.17B | 117.50 | $48.71B | 60.04 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $195.16 | $66.11 | 195.22% | 84.48x | 26.16x | 15.21x | 4.04x | 1.37x | $30.76M | 0.80% | $950.17M | 48.53 | $4.15B | 40.31 | ||
| VCEL | VERICEL CORP | $37.59 | $6.70 | 461.05% | 144.58x | 137.14x | 7.34x | 5.91x | 2.69x | $20.38M | 1.07% | $321.86M | 6.38 | $1.90B | 64.78 | ||
| TECH | BIO-TECHNE CORP | $59.24 | $16.48 | 259.52% | 118.48x | 29.30x | 7.57x | 4.70x | 1.62x | $224.06M | 2.43% | $1.97B | 12.65 | $9.48B | 42.92 | ||
| RPRX | ROYALTY PHARMA PLC | $39.08 | $42.71 | -8.51% | 22.20x | 8.13x | 7.18x | 2.34x | 0.45x | $2.11B | 12.51% | $9.62B | 22.28 | $30.57B | 29.27 | ||
| KRYS | KRYSTAL BIOTECH INC | $253.68 | $68.29 | 271.50% | 36.77x | 40.61x | 19.68x | 6.46x | 3.34x | $166.02M | 2.26% | $1.14B | 39.30 | $6.97B | 36.07 | ||
| VCYT | VERACYTE INC | $42.88 | $9.33 | 359.58% | 109.95x | 80.84x | 6.82x | 2.70x | 2.25x | $98.21M | 2.91% | $1.26B | 15.98 | $3.11B | 54.62 | ||
| CRMD | CORMEDIX INC | $12.73 | $13.37 | -4.78% | 5.61x | 5.09x | 4.51x | 2.68x | 27.91x | $74.42M | 7.70% | $374.13M | 4.93 | $1.10B | 9.83 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $1.79 | $1.31 | 36.31% | 25.57x | 70.75x | 2.29x | 2.72x | 0.73x | -$11.69M | -8.21% | $52.91M | 0.67 | $138.48M | 15.61 | ||
| HALO | HALOZYME THERAPEUTICS INC | $68.95 | $76.00 | -9.28% | 14.10x | 10.77x | 6.50x | 16.09x | 0.54x | $602.40M | 7.45% | $503.92M | 4.30 | $9.20B | 10.88 | ||
| GYRE | GYRE THERAPEUTICS INC | $7.16 | $0.76 | 841.29% | 102.29x | 46.80x | 6.06x | 6.77x | 7.51x | $3.05M | 0.47% | $101.92M | 1.12 | $650.51M | 49.17 | ||
| AUPH | AURINIA PHARMACEUTICALS INC | $15.89 | $8.27 | 92.24% | 27.40x | 20.23x | 7.88x | 5.73x | 1.20x | $119.87M | 5.72% | $365.77M | 2.78 | $2.10B | 20.29 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $60.04 | $43.31 | 38.63% | 22.07x | 20.02x | 3.73x | 1.90x | 0.81x | $832.13M | 7.22% | $6.06B | 31.54 | $10.88B | 14.08 | ||
| MNKD | MANNKIND CORP | $5.77 | $1.45 | 298.67% | 57.70x | 72.49x | 5.64x | -39.77x | 2.47x | $43.39M | 2.44% | -$44.55M | -0.15 | $2.00B | 27.39 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $459.78 | $171.74 | 167.71% | 32.13x | 24.60x | 10.02x | 6.74x | 1.93x | $3.34B | 2.84% | $17.32B | 67.76 | $113.55B | 24.36 | ||
| INVA | INNOVIVA INC | $19.72 | $15.51 | 27.17% | 10.43x | 9.21x | 3.51x | 1.46x | 1.62x | $196.54M | 14.43% | $1.01B | 14.63 | $1.26B | 5.85 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $37.91 | $37.17 | 2.00% | 11.74x | 11.63x | 2.64x | 2.61x | 0.76x | $296.89M | 13.61% | $835.12M | 14.51 | $1.70B | 6.32 | ||
| EXEL | EXELIXIS INC | $45.37 | $30.17 | 50.39% | 18.44x | 16.92x | 5.32x | 5.63x | 1.06x | $779.77M | 6.40% | $2.16B | 8.05 | $11.96B | 12.90 | ||
| ADMA | ADMA BIOLOGICS INC | $19.11 | $8.53 | 124.09% | 21.72x | 32.03x | 9.33x | 10.55x | 2.08x | $40.73M | 0.89% | $431.19M | 1.81 | $4.56B | 26.49 | ||
| INCY | INCYTE CORP | $99.29 | $68.68 | 44.58% | 16.44x | 14.23x | 4.04x | 4.19x | 1.10x | $1.20B | 6.16% | $4.65B | 23.77 | $17.07B | 10.15 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $6.59 | $3.35 | 96.72% | 24.41x | 35.51x | 4.22x | 7.44x | 1.37x | $21.15M | 4.02% | $70.68M | 0.89 | $464.69M | 20.48 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $24.06 | $12.35 | 94.86% | 13.44x | 14.95x | 5.10x | 3.21x | 4.60x | $234.54M | 7.95% | $920.25M | 7.51 | $2.27B | 7.01 | ||
| UTHR | UNITED THERAPEUTICS CORP | $502.90 | $201.73 | 149.29% | 17.66x | 18.22x | 7.04x | 3.29x | 5.16x | $1.12B | 5.09% | $6.59B | 150.46 | $20.31B | 11.46 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $780.50 | $372.93 | 109.29% | 17.96x | 17.78x | 5.68x | 2.65x | 2.41x | $4.22B | 5.22% | $30.96B | 298.82 | $82.23B | 14.40 | ||
| MDXG | MIMEDX GROUP INC | $6.91 | $2.80 | 146.99% | 24.68x | 16.13x | 2.60x | 4.28x | 2.19x | $66.82M | 6.53% | $238.95M | 1.61 | $899.52M | 13.00 | ||
| XOMA | XOMA ROYALTY CORP | $25.25 | $4.83 | 422.59% | 31.17x | 22.71x | 6.51x | 3.56x | 77.00x | -$12.41M | -4.05% | $87.94M | 7.25 | $354.11M | 13.24 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.